{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:40:05Z","timestamp":1792640405947,"version":"4.5.0"},"reference-count":33,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.2967\/jnumed.111.092734","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T05:00:22Z","timestamp":1326430822000},"page":"182-190","source":"Crossref","is-referenced-by-count":139,"title":["PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma"],"prefix":"10.2967","volume":"53","author":[{"given":"Michel","family":"van Kruchten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andor W.J.M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik F.J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina G.H.","family":"Beets-Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien P.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi A.","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth G.E.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geke A.P.","family":"Hospers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2012,1,12]]},"reference":[{"key":"2021051712025629000_53.2.182.1","unstructured":"Altekruse SF Kosary CL Krapcho M . SEER Cancer Statistics Review, 1975\u2013\u20132007. Bethesda, MD: National Cancer Institute; based on November 2009 SEER data submission. 2010. Available from: http:\/\/seer.cancer.gov. Accessed December 9, 2011."},{"key":"2021051712025629000_53.2.182.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.09.009"},{"key":"2021051712025629000_53.2.182.3","first-page":"155","article-title":"Prognostic and predictive factors in breast cancer by immunohistochemical analysis","volume":"11","author":"Allred","year":"1998","journal-title":"Mod Pathol."},{"key":"2021051712025629000_53.2.182.4","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J Clin Oncol."},{"key":"2021051712025629000_53.2.182.5","first-page":"4256s","article-title":"Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer","volume":"46","author":"DeSombre","year":"1986","journal-title":"Cancer Res."},{"key":"2021051712025629000_53.2.182.6","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-8-868"},{"key":"2021051712025629000_53.2.182.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2818.2007.01772.x"},{"key":"2021051712025629000_53.2.182.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.6529"},{"key":"2021051712025629000_53.2.182.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60993-8"},{"issue":"suppl","key":"2021051712025629000_53.2.182.10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1200\/jco.2010.28.15_suppl.1007","article-title":"Tissue confirmation of disease recurrence in patients with breast cancer: pooled analysis of two large prospective studies [abstract]","volume":"28","author":"Amir","year":"2010","journal-title":"J Clin Oncol."},{"key":"2021051712025629000_53.2.182.11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp028"},{"issue":"suppl","key":"2021051712025629000_53.2.182.12","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1200\/jco.2010.28.15_suppl.1009","article-title":"Discordance in hormone receptor status in breast cancer during tumor progression [abstract]","volume":"28","author":"Karlsson","year":"2010","journal-title":"J Clin Oncol."},{"key":"2021051712025629000_53.2.182.13","unstructured":"NCCN Clinical Practice Guidelines in Clinical Oncology, version 2.2011. 2011. Available from: http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/breast.pdf. Accessed December 9, 2011."},{"key":"2021051712025629000_53.2.182.14","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq160"},{"key":"2021051712025629000_53.2.182.15","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700543"},{"key":"2021051712025629000_53.2.182.16","first-page":"1766","article-title":"Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays","volume":"36","author":"Dehdashti","year":"1995","journal-title":"J Nucl Med."},{"key":"2021051712025629000_53.2.182.17","doi-asserted-by":"publisher","DOI":"10.2174\/138161208786404362"},{"key":"2021051712025629000_53.2.182.18","first-page":"1526","article-title":"Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma","volume":"32","author":"McGuire","year":"1991","journal-title":"J Nucl Med."},{"key":"2021051712025629000_53.2.182.19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1148\/radiology.169.1.3262228","article-title":"Breast cancer: PET imaging of estrogen receptors","volume":"169","author":"Mintun","year":"1988","journal-title":"Radiology."},{"key":"2021051712025629000_53.2.182.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.047506"},{"key":"2021051712025629000_53.2.182.21","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1200\/JCO.2001.19.11.2797","article-title":"Metabolic flare: indicator of hormone responsiveness in advanced breast cancer","volume":"19","author":"Mortimer","year":"2001","journal-title":"J Clin Oncol."},{"key":"2021051712025629000_53.2.182.22","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050359"},{"key":"2021051712025629000_53.2.182.23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.3810"},{"key":"2021051712025629000_53.2.182.24","doi-asserted-by":"publisher","DOI":"10.1016\/0969-8043(95)00330-4"},{"key":"2021051712025629000_53.2.182.25","first-page":"1","article-title":"FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging\u2014version 1.0","volume":"37","author":"Boellaard","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712025629000_53.2.182.26","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.1.47"},{"key":"2021051712025629000_53.2.182.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"issue":"suppl","key":"2021051712025629000_53.2.182.28","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/S0960-9776(09)70276-0","article-title":"Molecular imaging of breast cancer","volume":"18","author":"Oude Munnink","year":"2009","journal-title":"Breast."},{"key":"2021051712025629000_53.2.182.29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.5946"},{"key":"2021051712025629000_53.2.182.30","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/ajcp\/110.6.758","article-title":"Tissue heterogeneity of immunohistochemically detected estrogen receptor: implications for image analysis quantification","volume":"110","author":"Layfield","year":"1998","journal-title":"Am J Clin Pathol."},{"key":"2021051712025629000_53.2.182.31","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19851015)56:8<2019::AID-CNCR2820560822>3.0.CO;2-4"},{"key":"2021051712025629000_53.2.182.32","first-page":"933","article-title":"Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy","volume":"2","author":"Mortimer","year":"1996","journal-title":"Clin Cancer Res."},{"key":"2021051712025629000_53.2.182.33","first-page":"679","article-title":"[18F]fluoroestradiol radiation dosimetry in human PET studies","volume":"42","author":"Mankoff","year":"2001","journal-title":"J Nucl Med."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.111.092734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T19:37:29Z","timestamp":1621280249000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.111.092734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,12]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,1]]},"published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.2967\/jnumed.111.092734"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.111.092734","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,12]]}}}